WO2010115249A1 - Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy - Google Patents

Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy Download PDF

Info

Publication number
WO2010115249A1
WO2010115249A1 PCT/BR2009/000102 BR2009000102W WO2010115249A1 WO 2010115249 A1 WO2010115249 A1 WO 2010115249A1 BR 2009000102 W BR2009000102 W BR 2009000102W WO 2010115249 A1 WO2010115249 A1 WO 2010115249A1
Authority
WO
WIPO (PCT)
Prior art keywords
lactating animals
subclinical mastitis
treatment method
dynamic therapy
photosensitive agent
Prior art date
Application number
PCT/BR2009/000102
Other languages
French (fr)
Inventor
Livia Helena Moreira Da Silva
José Carlos Pereira de SOUZA
Katia Calligaris Rodrigues
Raduan Hege
Renato Amaro Zangaro
Original Assignee
Livia Helena Moreira Da Silva
Souza Jose Carlos Pereira De
Katia Calligaris Rodrigues
Raduan Hege
Renato Amaro Zangaro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Livia Helena Moreira Da Silva, Souza Jose Carlos Pereira De, Katia Calligaris Rodrigues, Raduan Hege, Renato Amaro Zangaro filed Critical Livia Helena Moreira Da Silva
Priority to PCT/BR2009/000102 priority Critical patent/WO2010115249A1/en
Publication of WO2010115249A1 publication Critical patent/WO2010115249A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0624Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/067Radiation therapy using light using laser light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0635Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0644Handheld applicators

Definitions

  • the present application of Invention Privilege belongs to the therapeutic procedures field having the objective of defining an innovative subclinical mastitis treatment method in lactating animals using "Photo Dynamic Therapy” (PDT), that consists on applying a photosensitive agent together laser irradiation on the infected mammary quarter, using an already existing low- energy laser emission equipment (LEDs), that can be adapted to any acrylic instrument tip, allowing its introduction from the animal teat orifice till the desired location, so the radiation reaches the entire glandular part of the infected teat in three different levels in only one application with an established nism to death without loss or excessive exposure.
  • PDT Photo Dynamic Therapy
  • LEDs low- energy laser emission equipment
  • bovine mastitis is currently one of the most serious problems found on dairy husbandry, with high prevalence in flocks all around the world that is being studied since the eighteenth century and even today with a lot of studies about this pathology, it still is the disease with highest economical impact over milk production.
  • Subclinical mastitis causes a silent reduction of the milk capacity secretion of the affected mammary quarter and it can cause a huge impact, since the use of veterinary antimicrobial (antibiotics) chemical substances increases.
  • the conventional treatment is done with intra mammary antibiotics application and, in last cases, when all the animal organism is affected, the application is parenteral (intramuscular).
  • the subclinical mastitis treatment with antibiotics in addition to present its residues on milk, can also produce residues on other animal origin products intended to human consumption and thus indirectly causing bacteria resistance on humans.
  • the Photo Dynamic Therapy is the use of a low-energy laser producing a photochemical effect when applied against living tissue and in bacteria's case is maximized with the pigment use (photosensitive agent) plus the laser irradiation.
  • the laser therapy was used in women on acute mastitis treatment applying a high power laser. Because animal's skin is very thick, a factor that decreases laser radiation absorption, the great innovation of Photo Dynamic Therapy to treat mastitis in lactating animals is the topic within the animal's mammary gland, as a more efficient method that maximizes the bacteria death in association the photosensitive agent administration.
  • LEDs low-energy laser

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Subclinical mastitis treatment method in lactating animals using photo dynamic therapy is an innovative therapeutic method to mastitis treatment in lactating animals that consists in an optical treatment within the animal's mammary gland, maximizing with more efficiency the bacteria death with the administration of photosensitive agent. Thus, it was used low-energy laser (LEDs) emission equipments with no thermal effect, already existents, substituting the usual tips by acrylic ones with specific dimensions that enable its penetration on the animal teat orifice to guide the light emission to reach the gland internally irradiating in three distinct deep levels with the energy density properly adjusted to each of them in only one application direct on the infection focus together the introduction of a photosensitive agent into the teat by a urethral probe, that stimulated by low-energy laser (LEDs) irradiation, has absorbed the radiation an has transmitted these captured energy to the cells, triggering the desired photosensitization effect, ie the death of microorganisms by light in presence of a photosensitive agent.

Description

METHOD FOR TREATMENT OF SUBCLINICAL MASTITIS IN LACTATING ANIMALS USING PHOTODYNAMIC THERAPY
Field of Invention
The present application of Invention Privilege belongs to the therapeutic procedures field having the objective of defining an innovative subclinical mastitis treatment method in lactating animals using "Photo Dynamic Therapy" (PDT), that consists on applying a photosensitive agent together laser irradiation on the infected mammary quarter, using an already existing low- energy laser emission equipment (LEDs), that can be adapted to any acrylic instrument tip, allowing its introduction from the animal teat orifice till the desired location, so the radiation reaches the entire glandular part of the infected teat in three different levels in only one application with an established nism to death without loss or excessive exposure.
The use of this innovative subclinical mastitis treatment method in lactating animals through Photo Dynamic Therapy (PDT) makes short, with total elimination of the microorganism, these infections duration, a fundamental importance aspect in control and prevention programs of mastitis during lactation; eliminates the effective milk secretion reduction, as the milked milk disposal, both originated by the infection by microorganism presence and by the antibiotics residues applied on usual treatments. History of Invention
Studies show that bovine mastitis is currently one of the most serious problems found on dairy husbandry, with high prevalence in flocks all around the world that is being studied since the eighteenth century and even today with a lot of studies about this pathology, it still is the disease with highest economical impact over milk production.
Subclinical mastitis causes a silent reduction of the milk capacity secretion of the affected mammary quarter and it can cause a huge impact, since the use of veterinary antimicrobial (antibiotics) chemical substances increases.
The conventional treatment is done with intra mammary antibiotics application and, in last cases, when all the animal organism is affected, the application is parenteral (intramuscular).
The concern with a growing antibiotics residues presence on milk generates a search for alternative methods to the classical approach of this substances, for example the use of homeopathic and biotherapy medicines prepared from bacteria, fungi, viruses, pathological secretions or excretions, mites, worms, etc. either animal or vegetal.
State of Technical Disabled Points
1 - The conventional long duration treatment to microorganism eradication with antibiotics application, either via mammary or injectable, compromises the milk quality by the antimicrobial chemical substance (antibiotics) presence, coming from the treatment, making necessary to discard the milk for up to 10 days.
2 - The subclinical mastitis treatment with antibiotics, in addition to present its residues on milk, can also produce residues on other animal origin products intended to human consumption and thus indirectly causing bacteria resistance on humans.
3 - The homeopathic medicines use, although the results are positive, the treatment has a long duration compromising the milk production.
4 - The biotherapy medicines application was effective on mastitis preventive treatment, but with a long duration on the infection treatment, also compromising the milk production.
Invention summary
Thinking about these problems that, after much research and studies, the inventors have created and developed an innovative subclinical mastitis treatment method, that eliminates the effective milk production reduction and disposal, meeting the increasingly stringent requirement of national and international institutions about the antimicrobial residues absence, through Photo Dynamic Therapy already known and used in humans on skin, intestine and other cancer treatments with low energy density and by dentists to eliminate any bacteria that may stay after a treatment before covering the tooth with high energy density, however never used on mastitis treatment.
The Photo Dynamic Therapy is the use of a low-energy laser producing a photochemical effect when applied against living tissue and in bacteria's case is maximized with the pigment use (photosensitive agent) plus the laser irradiation. The laser therapy was used in women on acute mastitis treatment applying a high power laser. Because animal's skin is very thick, a factor that decreases laser radiation absorption, the great innovation of Photo Dynamic Therapy to treat mastitis in lactating animals is the topic within the animal's mammary gland, as a more efficient method that maximizes the bacteria death in association the photosensitive agent administration.
Thus, it was used low-energy laser (LEDs) emission equipments with no thermal effect, already existents, substituting the usual tips by acrylic ones with 100 mm in length and 5 mm in diameter, that enables the penetration on the animal teat orifice to guide the light emission to reach the gland internally. Laser was irradiated in three distinct deep levels with the energy density properly adjusted in 200 J/ cm2 in each one, never tested in animals before, it enabled only one direct application on infection focus. It was also used an introduction of 1 ml of photosensitive agent, Toluidine blue, in teat by urethral probe with a 2,5% concentration, that stimulated by laser irradiation, transmits the captured energy to the cells, triggering the desired photo photosensitization effect, ie the death of microorganisms by light in the presence of a photosensitive agent.

Claims

1 - "SUBCLINICAL MASTITIS TREATMENT METHOD IN LACTATING ANIMALS USING PHOTO DYNAMIC THERAPY", characterized by an innovative subclinical mastitis treatment method in lactating animals with the usual Photo Dynamic Therapy (PDT) equipment acrylic tip adequacy, with the energy density (DE) properly adjusted, that enables the topic laser irradiation within the animal mammary gland in only one application in three deep levels and, also, the introduction of photosensitive agent toluidine blue in specific dosage, that when receiving the irradiation causes bactericidal effect, reducing this way the total bacterial count, eliminating the milk disposal by the microorganisms presence;
2 - "SUBCLINICAL MASTITIS TREATMENT METHOD IN LACTATING ANIMALS USING PHOTO DYNAMIC
THERAPY", according to the claim 1 , characterized by already existents PDT equipments adequacy with an acrylic tip with 100 mm length and 5 mm in diameter approximated dimensions, that enables in an efficient way its introduction on the animal teat orifice guiding the light emission (irradiation) through the infected mammary quarter till reach the desired treatment location;
3 - "SUBCLINICAL MASTITIS TREATMENT METHOD IN LACTATING ANIMALS USING PHOTO DYNAMIC THERAPY", according to claim 1 , characterized by the utilization of a photosensitive agent tuluidine blue with 2,5% concentration, with a bactericidal effect through light irradiation, injected by urethral probe introduced by the teat sphincter till it arrives on the gland cistern;
4 - "SUBCLINICAL MASTITIS TREATMENT METHOD IN LACTATING ANIMALS USING PHOTO DYNAMIC THERAPY", according to claim 1, characterized by having a energy density (DE) properly adjusted and applied in three deep levels in only one application of 200 J/cm2 in each level, being the level 1 near the glandular parenchyma, level 2 on the gland cistern and level 3 on teats base, irradiating for 262 seconds in each level;
5 - "SUBCLINICAL MASTITIS TREATMENT METHOD IN LACTATING ANIMALS USING PHOTO DYNAMIC THERAPY", according to the claim 1 , characterized by reduce the total bacterial count and eliminate milk disposal by the microorganisms presence and antibiotics residues applied during usual treatment.
PCT/BR2009/000102 2009-04-09 2009-04-09 Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy WO2010115249A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/BR2009/000102 WO2010115249A1 (en) 2009-04-09 2009-04-09 Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BR2009/000102 WO2010115249A1 (en) 2009-04-09 2009-04-09 Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy

Publications (1)

Publication Number Publication Date
WO2010115249A1 true WO2010115249A1 (en) 2010-10-14

Family

ID=42935589

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR2009/000102 WO2010115249A1 (en) 2009-04-09 2009-04-09 Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy

Country Status (1)

Country Link
WO (1) WO2010115249A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021151167A1 (en) * 2020-01-31 2021-08-05 Cosmoaesthetics Pty Ltd Wearable apparatus for the treatment of mastitis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0596018A (en) * 1991-10-09 1993-04-20 Matsushita Electric Ind Co Ltd Probe for laser treating device
US20060047329A1 (en) * 2003-10-15 2006-03-02 Yosef Krespi Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract
WO2006037599A1 (en) * 2004-10-03 2006-04-13 Stefan Bernhard Device for the prevention and treatment of mastitis with light
WO2007025244A2 (en) * 2005-08-25 2007-03-01 Houle Philip R Treatment systems for delivery of sensitizer solutions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0596018A (en) * 1991-10-09 1993-04-20 Matsushita Electric Ind Co Ltd Probe for laser treating device
US20060047329A1 (en) * 2003-10-15 2006-03-02 Yosef Krespi Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract
WO2006037599A1 (en) * 2004-10-03 2006-04-13 Stefan Bernhard Device for the prevention and treatment of mastitis with light
WO2007025244A2 (en) * 2005-08-25 2007-03-01 Houle Philip R Treatment systems for delivery of sensitizer solutions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021151167A1 (en) * 2020-01-31 2021-08-05 Cosmoaesthetics Pty Ltd Wearable apparatus for the treatment of mastitis

Similar Documents

Publication Publication Date Title
Wardlaw et al. Photodynamic therapy against common bacteria causing wound and skin infections
JP2007509034A (en) Antibacterial photodynamic therapeutic compounds based on erythrosin and methods of use thereof
CN101060816A (en) Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis
CN205268849U (en) Antibiotic photosensitive therapeutic instrument
JP2009013162A (en) Photosenstive acne therapeutic agent, photosenstive acne therapeutic agent composition, kit for photodynamic acne therapy, photosensitive sebum secretion inhibitor, photosensitive sebum secretion inhibitor composition and kit for photodynamic sebum secretion inhibitor
Šmucler et al. Comparative study of aminolevulic acid photodynamic therapy plus pulsed dye laser versus pulsed dye laser alone in treatment of viral warts
Moreira et al. Use of photodynamic therapy in the treatment of bovine subclinical mastitis
JP2007503917A (en) Antibacterial photodynamic therapeutic compounds and methods of use thereof
WO2010115249A1 (en) Method for treatment of subclinical mastitis in lactating animals using photodynamic therapy
RU2379073C2 (en) Method of laser treatment of chronic tonsillitis with using photosensitiser
JP2018501829A (en) Medical and veterinary light irradiation for therapeutic compounds
KR20130011162A (en) The method for treating tumor or skin diseases using photodynamic therapy
KR101318659B1 (en) Alopecia seborrheica therapeutics which comprise tryptophan, and kits for photodynamic therapy containing the same
CN106614153A (en) Method for treating goldfish saprolegniasis
KR101308507B1 (en) Acne therapeutics and sebum secernent inhibitor which comprise tryptophan, and kits for photodynamic therapy containing the same
Robatto et al. Blue Ligth Emitting Diode in Treatment of Recurring Vulvovaginal Candidiasis: a Case Report
CN114728156B (en) Medical instrument and medical device
US20160354407A1 (en) Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light
RU2398607C1 (en) Therapy of background, precancerous, malignant and metastatic diseases
RU2609735C1 (en) Method of optimisation of photodynamic therapy of purulent wounds (versions)
KR101592145B1 (en) Apparatus for treating seborrhoeic dermatitis and sterilizing method for infection seborrhoeic dermatitis
RU2345796C2 (en) Method of mastopathy treatment and prevention in animals
RU2342962C1 (en) Method of ramex complex treatment
RU2784347C1 (en) Hydropressive laser photochemical debridement method
Al Timimi Cancer treatment based on the selective accumulation of a photosensitiser and laser light irradiation: A review

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09842851

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 21/12/2011)

122 Ep: pct application non-entry in european phase

Ref document number: 09842851

Country of ref document: EP

Kind code of ref document: A1